Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT, MRI, PET/SPECT, Multi-modal, Optical, Ultrasound, Photoacoustic (PAT), Reagents, Services), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Preclinical Imaging Market Growth & Trends
The global preclinical imaging market size is expected to reach USD 5.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.8% from 2022 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create additional demand for this market.
Nuclear medicine techniques (primarily, positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), optical imaging, micro computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT) and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality.
The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the market growth.
The market's prominent competitors are taking different initiatives such as funding’s and acquisitions of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, In November 2021, Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.
Preclinical Imaging Market Report Highlights
Preclinical Imaging Market Growth & Trends
The global preclinical imaging market size is expected to reach USD 5.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.8% from 2022 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create additional demand for this market.
Nuclear medicine techniques (primarily, positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), optical imaging, micro computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT) and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality.
The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the market growth.
The market's prominent competitors are taking different initiatives such as funding’s and acquisitions of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, In November 2021, Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.
Preclinical Imaging Market Report Highlights
- By product, the optical segment accounted for the largest revenue share in 2021 owing to its wide usage in small animal imaging and new drug discovery projects
- The multimodal imaging segment is expected to witness significant growth during the forecast period, owing to the technological advancements
- North America accounted for the largest revenue share in 2021, well-developed research infrastructure, a large number of Preclinical projects, and higher adoption rates of technically advanced devices in the region are some of the factors that can be attributed to this share
- Asia Pacific is anticipated to grow at a lucrative rate over the forecast period owing to the increased government funding for the development of the research and development sector
- Major players in the industry are focusing on launch of advanced technology and features such as artificial intelligence enabled systems
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Device outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. PRECLINICAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Technological Advancements
3.4.1.2. Growing Number of Investments and Funding in Research and Development
3.4.2. Market restraint analysis
3.4.2.1. Strict regulatory framework
3.5. Preclinical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. PRECLINICAL IMAGING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Services
4.2. Product Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Preclinical Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. CT imaging
4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. MRI imaging
4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. PET/SPECT imaging
4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Multi-modal imaging
4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Optical imaging
4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.6. Ultrasound imaging
4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.7. Photoacoustic imaging
4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.8. Reagents
4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.9. Services
4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PRECLINICAL IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Regional market share analysis, 2020 & 2028
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2020
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
5.7. North America
5.7.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.3. France
5.8.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.4. Italy
5.8.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.5. Spain
5.8.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9. Asia Pacific
5.9.1. Japan
5.9.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.2. China
5.9.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.3. India
5.9.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.4. South Korea
5.9.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10.3. Argentina
5.10.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11. MEA
5.11.1. Saudi Arabia
5.11.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11.2. South Africa
5.11.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11.3. UAE
5.11.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2020
6.3.4. Bruker Corporation
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Siemens Healthineers AG
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. GE Healthcare
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. TriFoil Imaging
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. PerkinElmer, Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. VisualSonic Inc. (Fujifilm)
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Mediso Ltd.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Agilent Technologies
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. MR Solutions
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. MILabs B.V.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Molecubes
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Device outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. PRECLINICAL IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Technological Advancements
3.4.1.2. Growing Number of Investments and Funding in Research and Development
3.4.2. Market restraint analysis
3.4.2.1. Strict regulatory framework
3.5. Preclinical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. PRECLINICAL IMAGING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Services
4.2. Product Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Preclinical Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. CT imaging
4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. MRI imaging
4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. PET/SPECT imaging
4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Multi-modal imaging
4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Optical imaging
4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.6. Ultrasound imaging
4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.7. Photoacoustic imaging
4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.8. Reagents
4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.9. Services
4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PRECLINICAL IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Regional market share analysis, 2020 & 2028
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2020
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
5.7. North America
5.7.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.3. France
5.8.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.4. Italy
5.8.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.8.5. Spain
5.8.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9. Asia Pacific
5.9.1. Japan
5.9.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.2. China
5.9.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.3. India
5.9.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.9.4. South Korea
5.9.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.10.3. Argentina
5.10.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11. MEA
5.11.1. Saudi Arabia
5.11.1.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11.2. South Africa
5.11.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
5.11.3. UAE
5.11.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2020
6.3.4. Bruker Corporation
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Siemens Healthineers AG
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. GE Healthcare
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. TriFoil Imaging
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. PerkinElmer, Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. VisualSonic Inc. (Fujifilm)
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Mediso Ltd.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Agilent Technologies
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. MR Solutions
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. MILabs B.V.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Molecubes
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 North America Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 3 North America Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 5 Canada Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 6 Europe Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 7 Europe Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 8 Germany Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 9 U.K. Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 10 France Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 11 Italy Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 12 Spain Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 13 APAC Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 14 APAC Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 15 Japan Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 16 China Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 17 India Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 18 South Korea Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 19 Latin America Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 20 Latin America Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 21 Brazil Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 23 Argentina Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 24 Middle East and Africa Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 25 Middle East and Africa Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 26 South Africa Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 27 Saudi Arabia Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 28 UAE Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 1 List of Abbreviation
Table 2 North America Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 3 North America Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 5 Canada Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 6 Europe Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 7 Europe Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 8 Germany Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 9 U.K. Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 10 France Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 11 Italy Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 12 Spain Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 13 APAC Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 14 APAC Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 15 Japan Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 16 China Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 17 India Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 18 South Korea Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 19 Latin America Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 20 Latin America Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 21 Brazil Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 23 Argentina Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 24 Middle East and Africa Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 25 Middle East and Africa Preclinical Imaging market, by region, 2018 - 2030 (USD Million)
Table 26 South Africa Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 27 Saudi Arabia Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
Table 28 UAE Preclinical Imaging market, by product, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical Imaging market: market outlook
Fig. 14 Preclinical Imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical Imaging market driver impact
Fig. 20 Preclinical Imaging market restraint impact
Fig. 21 Preclinical Imaging market strategic initiatives analysis
Fig. 22 Preclinical Imaging market: product movement analysis
Fig. 23 Preclinical Imaging market: product outlook and key takeaways
Fig. 24 CT imaging market estimates and forecast, 2018 - 2030
Fig. 25 MRI imaging market estimates and forecast, 2018 - 2030
Fig. 26 PET/SPECT imaging market estimates and forecast, 2018 - 2030
Fig. 27 Multi-modal imaging market estimates and forecast, 2018 - 2030
Fig. 28 Optical imaging market estimates and forecast, 2018 - 2030
Fig. 29 Ultrasound imaging market estimates and forecast, 2018 - 2030
Fig. 30 Photoacoustic imaging market estimates and forecast, 2018 - 2030
Fig. 31 Reagents market estimates and forecast, 2018 - 2030
Fig. 32 Services market estimates and forecast, 2018 - 2030
Fig. 33 Global Preclinical Imaging market: regional movement analysis
Fig. 34 Global Preclinical Imaging market: regional outlook and key takeaways
Fig. 35 Global market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe market estimates and forecast, 2018 - 2030
Fig. 55 U.K.
Fig. 56 U.K. market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 France
Fig. 60 France market estimates and forecast, 2018 - 2030
Fig. 61 Italy
Fig. 62 Italy market estimates and forecast, 2018 - 2030
Fig. 63 Spain
Fig. 64 Spain market estimates and forecast, 2018 - 2030
Fig. 65 Asia Pacific
Fig. 66 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 67 Japan
Fig. 68 Japan market estimates and forecast, 2018 - 2030
Fig. 69 China
Fig. 70 China market estimates and forecast, 2018 - 2030
Fig. 71 India
Fig. 72 India market estimates and forecast, 2018 - 2030
Fig. 73 South Korea
Fig. 74 South Korea market estimates and forecast, 2018 - 2030
Fig. 75 Latin America
Fig. 76 Latin America market estimates and forecast, 2018 - 2030
Fig. 77 Brazil
Fig. 78 Brazil market estimates and forecast, 2018 - 2030
Fig. 79 Mexico
Fig. 80 Mexico market estimates and forecast, 2018 - 2030
Fig. 81 Argentina
Fig. 82 Argentina market estimates and forecast, 2018 - 2030
Fig. 83 Middle East and Africa
Fig. 84 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 85 South Africa
Fig. 86 South Africa market estimates and forecast, 2018 - 2030
Fig. 87 Saudi Arabia
Fig. 88 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 89 UAE
Fig. 90 UAE market estimates and forecast, 2018 - 2030
Fig. 91 Participant categorization- Preclinical Imaging market
Fig. 92 Market share of key market players- Preclinical Imaging market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical Imaging market: market outlook
Fig. 14 Preclinical Imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical Imaging market driver impact
Fig. 20 Preclinical Imaging market restraint impact
Fig. 21 Preclinical Imaging market strategic initiatives analysis
Fig. 22 Preclinical Imaging market: product movement analysis
Fig. 23 Preclinical Imaging market: product outlook and key takeaways
Fig. 24 CT imaging market estimates and forecast, 2018 - 2030
Fig. 25 MRI imaging market estimates and forecast, 2018 - 2030
Fig. 26 PET/SPECT imaging market estimates and forecast, 2018 - 2030
Fig. 27 Multi-modal imaging market estimates and forecast, 2018 - 2030
Fig. 28 Optical imaging market estimates and forecast, 2018 - 2030
Fig. 29 Ultrasound imaging market estimates and forecast, 2018 - 2030
Fig. 30 Photoacoustic imaging market estimates and forecast, 2018 - 2030
Fig. 31 Reagents market estimates and forecast, 2018 - 2030
Fig. 32 Services market estimates and forecast, 2018 - 2030
Fig. 33 Global Preclinical Imaging market: regional movement analysis
Fig. 34 Global Preclinical Imaging market: regional outlook and key takeaways
Fig. 35 Global market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe market estimates and forecast, 2018 - 2030
Fig. 55 U.K.
Fig. 56 U.K. market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 France
Fig. 60 France market estimates and forecast, 2018 - 2030
Fig. 61 Italy
Fig. 62 Italy market estimates and forecast, 2018 - 2030
Fig. 63 Spain
Fig. 64 Spain market estimates and forecast, 2018 - 2030
Fig. 65 Asia Pacific
Fig. 66 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 67 Japan
Fig. 68 Japan market estimates and forecast, 2018 - 2030
Fig. 69 China
Fig. 70 China market estimates and forecast, 2018 - 2030
Fig. 71 India
Fig. 72 India market estimates and forecast, 2018 - 2030
Fig. 73 South Korea
Fig. 74 South Korea market estimates and forecast, 2018 - 2030
Fig. 75 Latin America
Fig. 76 Latin America market estimates and forecast, 2018 - 2030
Fig. 77 Brazil
Fig. 78 Brazil market estimates and forecast, 2018 - 2030
Fig. 79 Mexico
Fig. 80 Mexico market estimates and forecast, 2018 - 2030
Fig. 81 Argentina
Fig. 82 Argentina market estimates and forecast, 2018 - 2030
Fig. 83 Middle East and Africa
Fig. 84 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 85 South Africa
Fig. 86 South Africa market estimates and forecast, 2018 - 2030
Fig. 87 Saudi Arabia
Fig. 88 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 89 UAE
Fig. 90 UAE market estimates and forecast, 2018 - 2030
Fig. 91 Participant categorization- Preclinical Imaging market
Fig. 92 Market share of key market players- Preclinical Imaging market
